December 2008 Volume 42 Number 11, pp 705 - 771
---------------------------------------------------------------------
Announcing an open access option in British
Journal of Cancer.
An open access option is now available to all
authors of original research papers that are
accepted for publication in BJC. BJC OPEN articles
will be freely accessible to all readers
immediately on publication.
Learn more about BJC OPEN by visiting BJC online at
http://links.ealert.nature.com/ctt?kn=24&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0.
---------------------------------------------------------------------
A combined print and online personal subscription to this journal
gives you your own print copy and access to the entire website
including all back issues. Purchasing a subscription is easy; use
our online order form at
http://links.ealert.nature.com/ctt?kn=19&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0 to start your
subscription today.
----------------------
REVIEW
----------------------
Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm?
D Bobak, L M Arfons, R J Creger and H M Lazarus
Abstract: http://links.ealert.nature.com/ctt?kn=42&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=17&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
----------------------
ORIGINAL ARTICLES
----------------------
400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
R M Sobecks, R Dean, L A Rybicki, J Chan, K S Theil, R Macklis, S Andresen, M Kalaycio, B Pohlman, C Ferraro, K Cherni, J Sweetenham, E Copelan and B J Bolwell
Abstract: http://links.ealert.nature.com/ctt?kn=51&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=29&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT
A Toor, T Rodriguez, M Bauml, H Mathews, S Shanti, D Senitzer, A Kini, J Norton, M Parthasarathy, N Mohideen, C Petrowsky, B Bonilla, S Smith and P Stiff
Abstract: http://links.ealert.nature.com/ctt?kn=76&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=54&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
G-CSF-stimulated BM progenitor cells supplement suboptimal peripheral blood hematopoietic progenitor cell collections for auto transplantation
T Seshadri, K Al-Farsi, J Stakiw, C Ma, R Saragosa, N Franke, A Keating, M Crump and J Kuruvilla
Abstract: http://links.ealert.nature.com/ctt?kn=71&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=41&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation
M Stelljes, A van Biezen, S Slavin, E Olavarria, R E Clark, A Nagler, V Koza, J Kienast, D Niederwieser, T de Witte and T Ruutu
Abstract: http://links.ealert.nature.com/ctt?kn=62&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=48&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
The syndrome of inappropriate secretion of antidiuretic hormone associated with SCT: clinical differences following SCT using cord blood and BM/peripheral blood
Y Suzuki, R Kobayashi, A Iguchi, T Sato, M Kaneda, K Kobayashi and T Ariga
Abstract: http://links.ealert.nature.com/ctt?kn=12&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=44&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
BM-derived cells randomly contribute to neoplastic and non-neoplastic epithelial tissues at low rates
D Soldini, E Moreno, V Martin, A Gratwohl, C Marone and L Mazzucchelli
Abstract: http://links.ealert.nature.com/ctt?kn=34&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=63&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD
L Magro, B Catteau, V Coiteux, B Bruno, J-P Jouet and I Yakoub-Agha
Abstract: http://links.ealert.nature.com/ctt?kn=28&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=35&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
----------------------
LETTERS TO THE EDITOR
----------------------
Myeloablative chemotherapy with autologous stem cell rescue for Ewing sarcoma
A L Gilman and J Oesterheld
http://links.ealert.nature.com/ctt?kn=15&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Response to Dr Gilman
M Eapen
http://links.ealert.nature.com/ctt?kn=39&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Sirolimus in unmanipulated haploidentical cell transplantation
L von Reyn Cream, W C Ehmann, W B Rybka and D F Claxton
http://links.ealert.nature.com/ctt?kn=4&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Plasma exchange after hematopoietic stem cell transplantation in multiple myeloma to reduce renal insufficiency
K Sullivan, S Jagannath, A Mazumder and D H Vesole
http://links.ealert.nature.com/ctt?kn=73&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose
M Remberger, J Mattsson, B-M Svahn and O Ringden
http://links.ealert.nature.com/ctt?kn=56&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
---------------------------------------------------------------------
Are you looking to reach a highly-skilled market for your recruitment
or classified ads?
Nature Publishing Group can offer you a portfolio of prestigious
journals that are targeted down to a specific sub-specialization.
With over 40 specialist titles to choose from, you can attract a
highly-skilled targeted audience within a number of scientific
disciplines. Both print and online options are available.
Contact your Naturejobs regional representative today:
W: http://links.ealert.nature.com/ctt?kn=32&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
E: naturejobs@nature.com
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=20&m=30644639&r=MTM5MDI2MzYyNgS2&b=2&j=NDM3ODYxNzUS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2008 Nature Publishing Group
=====================================================================
